» Articles » PMID: 36016613

Machine-learning-based Contrast-enhanced Computed Tomography Radiomic Analysis for Categorization of Ovarian Tumors

Overview
Journal Front Oncol
Specialty Oncology
Date 2022 Aug 26
PMID 36016613
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: This study aims to evaluate the diagnostic performance of machine-learning-based contrast-enhanced CT radiomic analysis for categorizing benign and malignant ovarian tumors.

Methods: A total of 1,329 patients with ovarian tumors were randomly divided into a training cohort (N=930) and a validation cohort (N=399). All tumors were resected, and pathological findings were confirmed. Radiomic features were extracted from the portal venous phase images of contrast-enhanced CT. The clinical predictors included age, CA-125, HE-4, ascites, and margin of tumor. Both radiomics model (including selected radiomic features) and mixed model (incorporating selected radiomic features and clinical predictors) were constructed respectively. Six classifiers [k-nearest neighbor (KNN), support vector machines (SVM), random forest (RF), logistic regression (LR), multi-layer perceptron (MLP), and eXtreme Gradient Boosting (XGBoost)] were used for each model. The mean relative standard deviation (RSD) and area under the receiver operating characteristic curve (AUC) were applied to evaluate and select the best classifiers. Then, the performances of the two models with selected classifiers were assessed in the validation cohort.

Results: The MLP classifier with the least RSD (1.21 and 0.53, respectively) was selected as the best classifier in both radiomics and mixed models. The two models with MLP classifier performed well in the validation cohort, with the AUCs of 0.91 and 0.96 and with accuracies (ACCs) of 0.83 and 0.87, respectively. The Delong test showed that the AUC of mixed model was statistically different from that of radiomics model (<0.001).

Conclusions: Machine-learning-based CT radiomic analysis could categorize ovarian tumors with good performance preoperatively. The mixed model with MLP classifier may be a potential tool in clinical applications.

Citing Articles

Radiomics and radiogenomics: extracting more information from medical images for the diagnosis and prognostic prediction of ovarian cancer.

Zeng S, Wang X, Yang H Mil Med Res. 2024; 11(1):77.

PMID: 39673071 PMC: 11645790. DOI: 10.1186/s40779-024-00580-1.


F-Fluoro-2-Deoxyglucose Positron Emission Tomography/Computed Tomography Measures of Spatial Heterogeneity for Predicting Platinum Resistance of High-Grade Serous Ovarian Cancer.

Zhang X, Lin Y, He D, Sun M, Xu L, Chang Z Cancer Med. 2024; 13(20):e70287.

PMID: 39435561 PMC: 11494247. DOI: 10.1002/cam4.70287.


Advances in ovarian cancer radiomics: a bibliometric analysis from 2010 to 2024.

Lan W, Hong J, Huayun T Front Oncol. 2024; 14:1456932.

PMID: 39411123 PMC: 11473287. DOI: 10.3389/fonc.2024.1456932.


CT-based radiomic analysis for categorization of ovarian sex cord-stromal tumors and epithelial ovarian cancers.

Liu Y, Zheng X, Fan D, Shen Z, Wu Z, Li S Abdom Radiol (NY). 2024; 49(11):4131-4139.

PMID: 38896249 DOI: 10.1007/s00261-024-04437-y.


Concomitant Prediction of the Ki67 and PIT-1 Expression in Pituitary Adenoma Using Different Radiomics Models.

Liu F, Zang Y, Feng L, Shi X, Wu W, Liu X J Imaging Inform Med. 2024; 38(1):394-409.

PMID: 38750186 PMC: 11810862. DOI: 10.1007/s10278-024-01121-x.


References
1.
Janssen C, Littooij A, Fiocco M, Huige J, de Krijger R, Hulsker C . The diagnostic value of magnetic resonance imaging in differentiating benign and malignant pediatric ovarian tumors. Pediatr Radiol. 2020; 51(3):427-434. PMC: 7897193. DOI: 10.1007/s00247-020-04871-2. View

2.
Gillies R, Kinahan P, Hricak H . Radiomics: Images Are More than Pictures, They Are Data. Radiology. 2015; 278(2):563-77. PMC: 4734157. DOI: 10.1148/radiol.2015151169. View

3.
Miao R, Badger T, Groesch K, Diaz-Sylvester P, Wilson T, Ghareeb A . Assessment of peritoneal microbial features and tumor marker levels as potential diagnostic tools for ovarian cancer. PLoS One. 2020; 15(1):e0227707. PMC: 6952086. DOI: 10.1371/journal.pone.0227707. View

4.
Nagawa K, Suzuki M, Yamamoto Y, Inoue K, Kozawa E, Mimura T . Texture analysis of muscle MRI: machine learning-based classifications in idiopathic inflammatory myopathies. Sci Rep. 2021; 11(1):9821. PMC: 8110584. DOI: 10.1038/s41598-021-89311-3. View

5.
Parmar C, Grossmann P, Rietveld D, Rietbergen M, Lambin P, Aerts H . Radiomic Machine-Learning Classifiers for Prognostic Biomarkers of Head and Neck Cancer. Front Oncol. 2015; 5:272. PMC: 4668290. DOI: 10.3389/fonc.2015.00272. View